PAMED News

PAMED has been informed by the Pennsylvania Department of Health (DOH) that a provider has voluntarily surrendered their DEA License, which means the provider is currently unable to prescribe controlled substances.

The State Boards of Medicine and Osteopathic Medicine finalize regulations to implement 20 Pa.C.S. § 8628, which requires physicians to complete at least 2 credit hours of continuing medical education in organ and tissue donation and recovery process.

The State Board of Medicine is proposing an overall update to its regulations, including standards relating to issuing licenses, certifications, permits and registrations; graduate medical training (GMT); and continuing education requirements.

The Patient Safety Authority and Department of Health issued updated guidance to acute health care facilities with reporting duties under the Medical Care Availability and Reduction of Error (MCARE) Act.

The U.S. Department of Justice and the Drug Enforcement Administration has announced the immediate rescheduling of FDA-approved products containing marijuana and marijuana products regulated by a state medical license to Schedule III from Schedule I.

This final rule implements requirements of the Administrative Simplification subtitle of the Health Insurance Portability and Accountability Act of 1996 (HIPAA), and the Patient Protection and Affordable Care Act by adopting standards for the electronic exchange of clinical and administrative documentation to support claims-related processes.

The Health Care Cost Containment Council (Council) is required to publish a list of all special reports and data that have been prepared during the previous calendar year.

The Authority has recommended that the FY 2025-2026 surcharge assessment total $1.245 million.

Upcoming Infant Hearing Screening Advisory Committee and Renal Disease Advisory Committee meetings.

Regulation #18-486: Seizure Disorder Regulation, approved by the Independent Regulatory Review Commission on January 15, 2026, has amended PA Code 67, Section 83.4, which will become effective on March 28, 2026.

The Patient Safety Authority (Authority) was established through the Medical Care Availability and Reduction of Error (MCARE) Act to collect, analyze and evaluate data regarding reports of serious events and incidents occurring in certain medical facilities and to make recommendations to reduce the number and severity of serious events and incidents.

The State Board of Pharmacy has published the patient income limits to participate in the Cancer Drug Repository Program (CDRP) in 2026.

In February 2024, the U.S. Department of Health and Human Services (Department) modified the Confidentiality of Substance Use Disorder Patient Records regulations (Part 2) to implement Section 3221 of the CARES Act, which required the Department to align Part 2 regulations more closely with the HIPAA regulations.

The Drug Enforcement Administration (DEA) jointly with the Department of Health and Human Services (HHS) is issuing a fourth extension of telemedicine flexibilities for the prescribing of controlled medications through December 31, 2026.

Regulatory updates and notices for new policies and open comment periods.

Regulatory updates from the Drug Enforcement Administration.

Regulatory Updates from Medicare and Medicaid Services.

The State Board of Nursing has worked with the DOH, State Boards of Medicine and Osteopathic Medicine, organ procurement organizations, and other agencies to develop an approved curriculum for continuing education in organ donation which is now available for providers.

The Department of Human Services (Department) announces changes to the Medical Assistance (MA) Program Fee Schedule.

The Department of Health published the guidelines and fees that a health care provider or facility may charge in response to a request for production of medical charts or records.